Group 1 - The company will hold an investor briefing on September 16, 2025, from 15:00 to 17:00 [2][4] - The briefing will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted in an online interactive format [3][4] - Investors can submit questions from September 9 to September 15, 2025, through the Roadshow Center website or via the company's email [2][5] Group 2 - The briefing aims to provide insights into the company's operating results and financial status for the first half of 2025 [2][3] - Key participants in the briefing will include the company's president, independent directors, financial director, and board secretary [5] - After the briefing, investors can access the main content and outcomes of the meeting on the Shanghai Stock Exchange Roadshow Center [7]
证券代码:688488 证券简称:艾迪药业 公告编号:2025-049